Sign in

CIK 0001799788 · Non-accelerated filer<br>Smaller reporting company

Greenwich LifeSciences, Inc.

Sign in to watch
Ticker
GLSI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
205473709
Phone
203-434-3290
Business address
3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-09-29 Patel Snehal CEO and CFO Purchase +16,667 $4.60 $77K 1,184,839
2020-09-29 Hallock Kenneth Director Purchase +8,333 $4.60 $38K 395,004
2020-09-29 Patel Snehal CEO and CFO Option exercise +176,448 1,040,131
2020-09-29 Patel Snehal CEO and CFO Option exercise +13,736 1,053,867
2020-09-29 Patel Snehal CEO and CFO Option exercise +10,394 1,064,261
2020-09-29 Patel Snehal CEO and CFO Option exercise +103,911 1,168,172
2020-09-29 Patel Snehal CEO and CFO Option exercise +1,144,529 1,321,327
2020-09-29 Patel Snehal CEO and CFO Option exercise +2,997 1,324,324
2020-09-29 Patel Snehal CEO and CFO Option exercise +33,708 1,358,032
2020-09-29 Patel Snehal CEO and CFO Option exercise +50,001 1,408,033
2020-09-29 Patel Snehal CEO and CFO Option exercise +76,780 76,780
2020-09-29 Patel Snehal CEO and CFO Option exercise +52,620 129,400
2020-09-29 Patel Snehal CEO and CFO Option exercise · Series A Preferred Stock −176,448 0
2020-09-29 Patel Snehal CEO and CFO Option exercise · Series A Preferred Stock −1,144,529 0
2020-09-29 Patel Snehal CEO and CFO Option exercise · Series B Preferred Stock −13,736 0
2020-09-29 Patel Snehal CEO and CFO Option exercise · Series B Preferred Stock −76,780 0
2020-09-29 Patel Snehal CEO and CFO Option exercise · Series B Preferred Stock −2,997 0
2020-09-29 Patel Snehal CEO and CFO Option exercise · Series C Preferred Stock −10,394 0
2020-09-29 Patel Snehal CEO and CFO Option exercise · Series C Preferred Stock −33,708 0
2020-09-29 Patel Snehal CEO and CFO Option exercise · Series D Preferred Stock −89,510 0

Page 8 of 10 · 190 trades